Three Psychedelic Presentations Available Now: Filament Health (FLHLF), NovaMind (NVMDF) and Wesana Health (WSNAF)

Presentations Recorded September 16th Replays Available. Sign up for free registration to view presentations.

Braxia Scientific Reports Q1, Up 80% From Expanding Clinic Patient Base

Braxia Scientific Reports First Quarter 2022 Financial Results; Company Achieves 80% Revenue Growth from Expanding Clinic Patient Base Revenue...

MindMed (MNMD) and Liechti Lab Provide Results from their Psilocybin R&D Collaboration

NEW YORK, Sept. 23, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing...

Ehave (EHVVF) Appoints LA’s ‘Top Doc’ Dr. Rahul Dixit, to Its Medical Advisory Board

To Assist and Advise the Company on Human Trials Ehave Appoints Board-Certified Gastroenterologist And Licensed Physician Dr....

Delic (DELCF) to Acquire Ketamine Wellness Centers Inc, Becoming Largest Psychedelic Wellness Chain in United States

Retail Footprint to Include 12 Open Locations, with 15 Additional Clinics in Development, Ensures Accessibility to Millions with Affordable Treatments and Insurance...

Maxim Mental Health and Psychedelic Conference

CLICK HERE Agenda 9:00 AM | AddictionFighting the pandemic within the pandemic John...

Greenbrook TMS (GBNH) Announces Increase to Bought Deal Financing to US$11.5 Million

TORONTO, September 22, 2021--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation...

Bright Minds Biosciences (BIMBF) Provides Scientific Update

Lead program, BMB-101, advances to IND-enabling toxicology studies with the aim of commencing human trials in 1H 2022

Small Pharma (DMTTF) Successfully Completes Phase I Clinical Trial Of DMT In Combination With Supportive Psychotherapy

Small Pharma's DMT-assisted therapy (SPL026) demonstrated to be well-tolerated and safe in psychedelic naïve volunteers Dataset generated from Phase...

Huge News on Opioid Addiction From atai (ATAI).

Every successful drug was once in Phase I. "In previously published non-controlled studies, ibogaine has demonstrated rapid and...

AdvisorShares Psychedelics ETF (PSIL)

The AdvisorShares Psychedelics ETF (NYSE ticker: PSIL) invests in the emerging psychedelic drugs sector, offering exposure to those biotechnology, pharmaceutical and life sciences companies...

Ketamine One (KONEF) Signs LOI with Veteran Services USA to Open Therapy Center

Ketamine-Assisted Treatment Facility to Be Part of a Medical Complex in Blue Island, Illinois

atai Life Sciences (ATAI) Increases Investment in IntelGenx’s (IGXT).

atai Life Sciences Increases Loan in Principal by US$6m to Support IntelGenx’s Graduation to Toronto Stock Exchange After Positive Early Feasibility...


Ketamine at Home Treatments

Most Popular

Ehave, Inc. Announces its KetaDASH Mobile Unit Delivered to Miami Beach.

MIAMI, June 03, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced...

Australian Icannex (IHL:ASX) Headed to NASDAQ?

Incannex completes Phase 2 trial for its cannabinoid drug for sleep apnea, flags Nasdaq listing in 2022

Testimonial: The Ibogaine Clinic, Playa Del Carmen